ATAGI Targeted Review 2022: Vaccination for prevention of herpes zoster in Australia Read more about ATAGI Targeted Review 2022: Vaccination for prevention of herpes zoster in Australia15 views
Disseminated varicella zoster virus infection following live attenuated herpes zoster vaccine: descriptive analysis of reports to Australia’s spontaneous vaccine pharmacovigilance system, 2016–2020 Read more about Disseminated varicella zoster virus infection following live attenuated herpes zoster vaccine: descriptive analysis of reports to Australia’s spontaneous vaccine pharmacovigilance system, 2016–20206 views
General practitioner knowledge gaps regarding live attenuated zoster vaccination of immunocompromised individuals. An ongoing concern? Read more about General practitioner knowledge gaps regarding live attenuated zoster vaccination of immunocompromised individuals. An ongoing concern? 6 views
Australia’s national zoster vaccination program: Knowledge, attitudes and behaviour of general practitioners Read more about Australia’s national zoster vaccination program: Knowledge, attitudes and behaviour of general practitioners58 views
Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine Read more about Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine77 views
Safety of live attenuated herpes zoster vaccine in adults 70 to 79 years: a self-controlled case series analysis using primary care data from the MedicineInsight program Read more about Safety of live attenuated herpes zoster vaccine in adults 70 to 79 years: a self-controlled case series analysis using primary care data from the MedicineInsight program55 views
Herpes zoster vaccination in Australia: what’s available and who benefits? Read more about Herpes zoster vaccination in Australia: what’s available and who benefits? 114 views
Risk of herpes zoster prior to and following cancer diagnosis and treatment: a population-based prospective cohort study Read more about Risk of herpes zoster prior to and following cancer diagnosis and treatment: a population-based prospective cohort study13 views
Evaluation of the National Shingles Vaccination Program Submitted by Anonymous on Fri, 05/04/2019 The National Shingles Vaccination Program was implemented from November 2016. This is the first major new vaccine program introduced for older Australians in more than a decade. The program provides free shingles vaccination, using Zostavax®, to adults aged 70 years, with a catch-up for those aged 71–79 years funded until 2021. The evaluation examined the implementation of the shingles vaccination program and also assessed vaccine coverage and safety data. Read more about Evaluation of the National Shingles Vaccination Program320 views